Gianluigi Poli

856 total citations
40 papers, 633 citations indexed

About

Gianluigi Poli is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gianluigi Poli has authored 40 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 18 papers in Physiology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gianluigi Poli's work include Inhalation and Respiratory Drug Delivery (24 papers), Asthma and respiratory diseases (18 papers) and Respiratory and Cough-Related Research (8 papers). Gianluigi Poli is often cited by papers focused on Inhalation and Respiratory Drug Delivery (24 papers), Asthma and respiratory diseases (18 papers) and Respiratory and Cough-Related Research (8 papers). Gianluigi Poli collaborates with scholars based in Italy, France and United Kingdom. Gianluigi Poli's co-authors include Daniela Acerbi, Wilfried De Backer, Knut Sommerer, C Herpich, Thomas Meyer, Raffaella Monno, Ashley Woodcock, A. Devolder, Wim Vos and Jan De Backer and has published in prestigious journals such as Clinical Pharmacokinetics, European Journal of Pharmaceutics and Biopharmaceutics and British Journal of Clinical Pharmacology.

In The Last Decade

Gianluigi Poli

39 papers receiving 601 citations

Peers

Countries citing papers authored by Gianluigi Poli

Since Specialization

Citations

This map shows the geographic impact of Gianluigi Poli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianluigi Poli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianluigi Poli more than expected).

Fields of papers citing papers by Gianluigi Poli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianluigi Poli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianluigi Poli. The network helps show where Gianluigi Poli may publish in the future.

Co-authorship network of co-authors of Gianluigi Poli

This figure shows the co-authorship network connecting the top 25 collaborators of Gianluigi Poli. A scholar is included among the top collaborators of Gianluigi Poli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianluigi Poli. Gianluigi Poli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The low global warming potential propellant HFA-152a does not induce bronchoconstriction or impair mucociliary clearance 2025 ·Pulmonary Pharmacology & Therapeutics ·(unknown), Dave Singh, Kusum S. Mathews, (unknown), (unknown), (unknown), (unknown), Maria Foti, (unknown), Gianluigi Poli, (unknown)	1
2	Targeting the Small Airways with Inhaled Corticosteroid/Long-Acting Beta Agonist Dry Powder Inhalers: A Functional Respiratory Imaging Study 2021 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Henrik Watz, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Dursun Duman, Gianluigi Poli, Leonardo M. Fabbri	18
3	Lung Deposition of the Dry Powder Fixed Combination Beclometasone Dipropionate Plus Formoterol Fumarate Using NEXThaler ^® Device in Healthy Subjects, Asthmatic Patients, and COPD Patients 2018 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·J. Christian Virchow, Gianluigi Poli, C Herpich, (unknown), (unknown), (unknown), Knut Sommerer, Sabine Häußermann, (unknown)	32
4	Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study 2018 ·Advances in Therapy ·Nassim Kamar, Élisabeth Cassuto, Giovanni Piotti, Mirco Govoni, (unknown), (unknown), Gianluigi Poli, Gabriele Nicolini, Christophe Mariat, Marie Essig, Paolo Malvezzi, Yannick Le Meur, Valérie Garrigue, Arnaud Del Bello, Lionel Rostaing	23
5	Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma 2016 ·Expert Review of Respiratory Medicine ·Ernesto Crisafulli, Andrea Zanini, Giovanna Pisi, Patrizia Pignatti, Gianluigi Poli, Mario Scuri, Alfredo Chetta	10
6	The Effects of Extrafine Beclometasone/Formoterol (BDP/F) on Lung Function, Dyspnea, Hyperinflation, and Airway Geometry in COPD Patients: Novel Insight Using Functional Respiratory Imaging 2014 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Jan De Backer, Wim Vos, Samir Vinchurkar, Cedric Van Holsbeke, Gianluigi Poli, Rita Claes, Rodrigo Salgado, Wilfried De Backer	47
7	Systemic exposure to inhaled beclometasone/formoterol DPI is age and body size dependent 2014 ·Respiratory Medicine ·Bo Chawes, Mirco Govoni, Eskil Kreiner‐Møller, Nadja Hawwa Vissing, Porntiva Poorisrisak, Li Juel Mortensen, Erik Nilsson, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Francesco Sergio, (unknown), Gianluigi Poli, Daniela Acerbi, Dave Singh, Hans Bisgaard	9
8	Novel Functional Imaging of Changes in Small Airways of Patients Treated with Extrafine Beclomethasone/Formoterol 2013 ·Respiration ·Wim Vos, Jan De Backer, Gianluigi Poli, (unknown), L. Ghys, Cedric Van Holsbeke, Samir Vinchurkar, (unknown), Wilfried De Backer	48
9	Pharmacokinetic and tolerability profiles of tobramycin nebuliser solution 300 mg/4 ml administered by PARI eFlow® rapid and PARI LC Plus® nebulisers in cystic fibrosis patients 2012 ·Pulmonary Pharmacology & Therapeutics ·Mirco Govoni, Gianluigi Poli, Daniela Acerbi, Debora Santoro, Helen Cicirello, (unknown), (unknown)	15
10	Effect of AeroChamber Plus™ on the lung and systemic bioavailability of beclometasone dipropionate/formoterol pMDI 2011 ·British Journal of Clinical Pharmacology ·Dave Singh, (unknown), Gianluigi Poli, Daniela Acerbi, (unknown), (unknown)	23
11	Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial 2011 ·BMC Pulmonary Medicine ·Brian O’Connor, (unknown), Gianluigi Poli, Caterina Brindicci, Monica Spinola, Daniela Acerbi, Peter J. Barnes, Brian Leaker	10
12	Lung Deposition of BDP/Formoterol HFA pMDI in Healthy Volunteers, Asthmatic, and COPD Patients 2010 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Wilfried De Backer, A. Devolder, Gianluigi Poli, Daniela Acerbi, Raffaella Monno, C Herpich, Knut Sommerer, Thomas Meyer, (unknown)	132
13	Systemic Exposure and Implications for Lung Deposition with an Extra-Fine Hydrofluoroalkane Beclometasone Dipropionate/Formoterol Fixed Combination 2009 ·Clinical Pharmacokinetics ·Jean Bousquet, Gianluigi Poli, Daniela Acerbi, Raffaella Monno, Steven Ramael, (unknown)	22
14	Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients 2008 ·Pulmonary Pharmacology & Therapeutics ·Dave Singh, (unknown), Zöe Borrill, Gianluigi Poli, Daniela Acerbi, Luc Meuleners, Ashley Woodcock	14
15	Lung Deposition of Formoterol HFA (Atimos ^® /Forair ^® ) in Healthy Volunteers, Asthmatic and COPD Patients 2007 ·Journal of Aerosol Medicine ·Sabine Häußermann, Daniela Acerbi, Peter Brand, C Herpich, Gianluigi Poli, Knut Sommerer, Thomas Meyer	32
16	Modulite® technology: pharmacodynamic and pharmacokinetic implications 2002 ·Respiratory Medicine ·Ashley Woodcock, Daniela Acerbi, Gianluigi Poli	35
17	14C-NaVP and14C-PEV repeated dose study in rat pharmacokinetic study in rats after repeated oral administrations of14C-valproic acid sodium salt and14C-valproic acid pivaloyl oxymethyl ester 1998 ·European Journal of Drug Metabolism and Pharmacokinetics ·(unknown), Daniela Acerbi, S. Canali, C. Giachetti, Gianluigi Poli, Paolo Ventura, G Zanolo	0
18	Food effect on the oral bioavailability of Manidipine: single dose, randomized, crossover study in healthy male subjects 1998 ·European Journal of Drug Metabolism and Pharmacokinetics ·Dominique Rosillon, Armel Stockis, Gianluigi Poli, Daniela Acerbi, R. Lins, (unknown)	12
19	Comparative bioavailability of two oral formulations of ipriflavone in healthy volunteers at steady-state. Evaluation of two different dosage schemes 1998 ·European Journal of Drug Metabolism and Pharmacokinetics ·Daniela Acerbi, Gianluigi Poli, Paolo Ventura	2
20	Bioavailability and pharmacokinetics of a fixed combination of delapril/indapamide following single and multiple dosing in healthy volunteers 1994 ·European Journal of Drug Metabolism and Pharmacokinetics ·(unknown), G Pabst, (unknown), Gianluigi Poli, Daniela Acerbi	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact